Inappropriate use of food quality standards for seafood-derived complementary medicines

• 1 Bioactive Molecule Discovery
• 2 Bioinnovation
• 3 Bioinnovation, Australian Institute of Marine Science, PMB 3, Townsville, QLD 4810.

---

• 1. Standard 1.4.1 Contaminants and natural toxicants. Australia New Zealand Food Standards Code. Food Standards Australia New Zealand, 2003. Available at www.foodstandards.gov.au/foodstandardscode/ (accessed Feb 2004).
• 2. Alfonso A, Louzao MC, Vieytes MR, Botana LM. Comparative study of the stability of saxitoxin and neosaxitoxin in acidic solutions and lyophilized samples. Toxicon 1994; 32: 1593-1598.
• 3. Baden DG. Brevetoxins: unique polyether dinoflagellate toxins. FASEB J 1989; 3: 1807-1817.
• 4. Therapeutic Goods (Listing) Notice 1999 (No. 3). Canberra: Therapeutic Goods Administration, 30 November, 1999. Available at www.health.gov.au/tga/docs/pdf/tgnlist3.pdf (accessed Feb 2004).
• 5. Mo C, Neilson B. Standardization of oyster soft tissue dry weight measurements. Water Res 1994; 28: 243-246.
• 6. Suganuma M, Fujiki H, Suguri H, et al. Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumour promoter. Proc Natl Acad Sci USA 1988; 85: 1768-1771.
• 7. Cordier S, Monfort C, Miossec L, et al. Ecological analysis of digestive cancer mortality related to contamination by diarrhetic shellfish poisoning toxins along the coasts of France. Environ Res 2000; 84: 145-150.
• 8. Gago-Martinez A, Rodriguez-Vazquez JA, Thibault P, Quilliam MA. Simultaneous occurrence of diarrhetic and paralytic shellfish poisoning toxins in Spanish mussels in 1993. Nat Toxins 1996; 4: 72-79.